Taken together, these data suggest that Kremen2 interacts with SOCS3 and stabilizes the EGFR protein by preventing SOCS3-mediated EGFR ubiquitination and degradation; thereby, enhancing the activation of EGFR signaling and promoting cell proliferation and metastasis of NSCLC. Here, KREMEN2 is linked to non-small cell lung carcinoma.